BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 20610624)

  • 21. MiR-21/RASA1 axis affects malignancy of colon cancer cells via RAS pathways.
    Gong B; Liu WW; Nie WJ; Li DF; Xie ZJ; Liu C; Liu YH; Mei P; Li ZJ
    World J Gastroenterol; 2015 Feb; 21(5):1488-97. PubMed ID: 25663768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways.
    Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Shankar S; Srivastava RK
    PLoS One; 2014; 9(4):e92161. PubMed ID: 24694877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells.
    Tsunoda T; Takashima Y; Yoshida Y; Doi K; Tanaka Y; Fujimoto T; Machida T; Ota T; Koyanagi M; Kuroki M; Sasazuki T; Shirasawa S
    Anticancer Res; 2011 Jul; 31(7):2453-9. PubMed ID: 21873159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers.
    Wolfe AR; Feng H; Zuniga O; Rodrigues H; Eldridge DE; Yang L; Shen C; Williams TM
    Cancer Lett; 2024 Jun; 591():216873. PubMed ID: 38604313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.
    Fu X; Cui Y; Yang S; Xu Y; Zhang Z
    Tumour Biol; 2016 May; 37(5):6477-83. PubMed ID: 26631045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma.
    Zhang Y; Kim J; Mueller AC; Dey B; Yang Y; Lee DH; Hachmann J; Finderle S; Park DM; Christensen J; Schiff D; Purow B; Dutta A; Abounader R
    Cell Death Differ; 2014 May; 21(5):720-34. PubMed ID: 24440911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs impair MET-mediated invasive growth.
    Migliore C; Petrelli A; Ghiso E; Corso S; Capparuccia L; Eramo A; Comoglio PM; Giordano S
    Cancer Res; 2008 Dec; 68(24):10128-36. PubMed ID: 19074879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis.
    Hashimoto Y; Akiyama Y; Otsubo T; Shimada S; Yuasa Y
    Carcinogenesis; 2010 May; 31(5):777-84. PubMed ID: 20080834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase.
    Tokumaru Y; Tajirika T; Sugito N; Kuranaga Y; Shinohara H; Tsujino T; Matsuhashi N; Futamura M; Akao Y; Yoshida K
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation at Ser-181 of oncogenic KRAS is required for tumor growth.
    Barceló C; Paco N; Morell M; Alvarez-Moya B; Bota-Rabassedas N; Jaumot M; Vilardell F; Capella G; Agell N
    Cancer Res; 2014 Feb; 74(4):1190-9. PubMed ID: 24371225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-200c inhibits breast cancer proliferation by targeting KRAS.
    Song C; Liu LZ; Pei XQ; Liu X; Yang L; Ye F; Xie X; Chen J; Tang H; Xie X
    Oncotarget; 2015 Oct; 6(33):34968-78. PubMed ID: 26392416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamate increases pancreatic cancer cell invasion and migration via AMPA receptor activation and Kras-MAPK signaling.
    Herner A; Sauliunaite D; Michalski CW; Erkan M; De Oliveira T; Abiatari I; Kong B; Esposito I; Friess H; Kleeff J
    Int J Cancer; 2011 Nov; 129(10):2349-59. PubMed ID: 21207374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy of pancreatic cancer targeting the K-Ras oncogene.
    Lisiansky V; Naumov I; Shapira S; Kazanov D; Starr A; Arber N; Kraus S
    Cancer Gene Ther; 2012 Dec; 19(12):862-9. PubMed ID: 23099885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.
    Qin Y; Dang X; Li W; Ma Q
    Oncol Res; 2013; 21(6):353-63. PubMed ID: 25198665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-mediated regulation of KRAS in cancer.
    Kim M; Slack FJ
    J Hematol Oncol; 2014 Nov; 7():84. PubMed ID: 25433809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
    Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
    Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin.
    Rachagani S; Senapati S; Chakraborty S; Ponnusamy MP; Kumar S; Smith LM; Jain M; Batra SK
    Br J Cancer; 2011 Mar; 104(6):1038-48. PubMed ID: 21364589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors.
    Jiao LR; Frampton AE; Jacob J; Pellegrino L; Krell J; Giamas G; Tsim N; Vlavianos P; Cohen P; Ahmad R; Keller A; Habib NA; Stebbing J; Castellano L
    PLoS One; 2012; 7(2):e32068. PubMed ID: 22384141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR‑96 functions as a tumor suppressor gene by targeting NUAK1 in pancreatic cancer.
    Huang X; Lv W; Zhang JH; Lu DL
    Int J Mol Med; 2014 Dec; 34(6):1599-605. PubMed ID: 25242509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.